Literature DB >> 7960142

CD4+ and CD8+ T-cell-dependent and -independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice.

J W Conlan1, A Sjöstedt, R J North.   

Abstract

Immunity to experimental infection with the facultative intracellular bacterium Francisella tularensis is generally considered an example of T-cell-mediated, macrophage-expressed immunity. However, the results of the present study indicate that T-cell-independent mechanisms are also important in anti-Francisella defense. They show that mice selectively depleted of CD4+, CD8+, or both T-cell populations by treatment with T-cell subset-specific monoclonal antibodies remained capable of controlling and partly resolving a primary sublethal Francisella infection. Similarly, it was found that Francisella-immune mice depleted of either or both subsets of T cells retain a high degree of acquired immunity to reinfection. Together, these findings imply that resistance to primary and secondary tularemia can be mediated by cells other than CD4+ and CD8+ T cells.

Entities:  

Mesh:

Year:  1994        PMID: 7960142      PMCID: PMC303308          DOI: 10.1128/iai.62.12.5603-5607.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  T-cell subsets in delayed-type hypersensitivity, protection, and granuloma formation in primary and secondary Listeria infection in mice: superior role of Lyt-2+ cells in acquired immunity.

Authors:  M E Mielke; S Ehlers; H Hahn
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

Review 2.  Natural killer cells and interferon.

Authors:  R M Welsh
Journal:  Crit Rev Immunol       Date:  1984       Impact factor: 2.214

3.  On the mechanism of T cell-independent anti-Listeria resistance in nude mice.

Authors:  M F Newborg; R J North
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

4.  Effects of purified anti-Lyt-2 mAb treatment on murine listeriosis: comparative roles of Lyt-2+ and L3T4+ cells in resistance to primary and secondary infection, delayed-type hypersensitivity and adoptive transfer of resistance.

Authors:  C J Czuprynski; J F Brown
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

5.  The requirement for gamma interferon in resistance of mice to experimental tularemia.

Authors:  L S Anthony; E Ghadirian; F P Nestel; P A Kongshavn
Journal:  Microb Pathog       Date:  1989-12       Impact factor: 3.738

6.  Expression of Thy-1 antigen is not limited to T cells in cultures of mouse hemopoietic cells.

Authors:  J W Schrader; F Battye; R Scollay
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

Review 7.  Nature of protective immunity to Francisella tularensis.

Authors:  A Tärnvik
Journal:  Rev Infect Dis       Date:  1989 May-Jun

8.  Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance.

Authors:  L S Anthony; P A Kongshavn
Journal:  Microb Pathog       Date:  1987-01       Impact factor: 3.738

9.  Anomalous high native resistance to athymic mice to bacterial pathogens.

Authors:  A D Nickol; P F Bonventre
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

10.  Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection.

Authors:  N A Buchmeier; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

View more
  38 in total

1.  Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4.

Authors:  Stephen H Gregory; Wilbur H Chen; Stephanie Mott; John E Palardy; Nicholas A Parejo; Sara Heninger; Christine A Anderson; Andrew W Artenstein; Steven M Opal; Alan S Cross
Journal:  Vaccine       Date:  2010-02-17       Impact factor: 3.641

2.  In vivo mechanisms involved in enhanced protection utilizing an Fc receptor-targeted mucosal vaccine platform in a bacterial vaccine and challenge model.

Authors:  Constantine Bitsaktsis; Zulfia Babadjanova; Edmund J Gosselin
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

3.  Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.

Authors:  Rebecca V Anderson; Deborah D Crane; Catharine M Bosio
Journal:  Vaccine       Date:  2010-08-03       Impact factor: 3.641

4.  Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS.

Authors:  Michael D Valentino; Lucinda L Hensley; Denise Skrombolas; Pamela L McPherson; Matthew D Woolard; Thomas H Kawula; Jeffrey A Frelinger; John G Frelinger
Journal:  Mol Immunol       Date:  2009-02-23       Impact factor: 4.407

Review 5.  An approach to the identification of T cell epitopes in the genomic era: application to Francisella tularensis.

Authors:  Michael Valentino; John Frelinger
Journal:  Immunol Res       Date:  2009-02-11       Impact factor: 2.829

6.  Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS).

Authors:  Susan M Twine; Mireille D Petit; Kelly M Fulton; Robert V House; J Wayne Conlan
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

7.  The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensis.

Authors:  Gal Markel; Erez Bar-Haim; Eran Zahavy; Hila Cohen; Ofer Cohen; Avigdor Shafferman; Baruch Velan
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

Review 8.  Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development.

Authors:  Roger D Pechous; Travis R McCarthy; Thomas C Zahrt
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

9.  Genetic variation in neutrophil accumulation in mice is not mediated through immigrant regulatory cells.

Authors:  S B Marley; C L Hadley; D Wakelin
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

10.  Epitope-based vaccination against pneumonic tularemia.

Authors:  Stephen H Gregory; Stephanie Mott; Jennifer Phung; Jinhee Lee; Leonard Moise; Julie A McMurry; William Martin; Anne S De Groot
Journal:  Vaccine       Date:  2009-07-17       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.